T. Rowe Price Health Sciences Fund, Inc. ALNY Holdings History
T. Rowe Price Health Sciences Fund, Inc.'s Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-03-31, T. Rowe Price Health Sciences Fund, Inc. held 1.14 Mil shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $308.99 Mil. This investment constitutes 2.71% of their stock portfolio, and T. Rowe Price Health Sciences Fund, Inc. now holds 0.88% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2019Q3. And since then T. Rowe Price Health Sciences Fund, Inc. has made 4 purchases of ALNY, at an average price of $121.58, for a total of 1.72 Mil shares. In addition, there have been 8 sales at an average price of $211.99 for 579,649.00 shares. Based on historical transaction data and ALNY's current price of $327.57, T. Rowe Price Health Sciences Fund, Inc.'s estimated gain on his ALNY holdings is $288.13 Mil, reflecting a 137.47% gain to date.
T. Rowe Price Health Sciences Fund, Inc. ALNY ($327.57) Holding Chart
T. Rowe Price Health Sciences Fund, Inc. ALNY ($327.57) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
